Estrogen-receptor polymorphism and hormone-replacement therapy
- PMID: 12214623
Estrogen-receptor polymorphism and hormone-replacement therapy
Comment on
-
Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease.N Engl J Med. 2002 Mar 28;346(13):967-74. doi: 10.1056/NEJMoa012952. N Engl J Med. 2002. PMID: 11919305 Clinical Trial.
-
Individualized hormone-replacement therapy?N Engl J Med. 2002 Mar 28;346(13):1017-8. doi: 10.1056/NEJM200203283461311. N Engl J Med. 2002. PMID: 11919312 No abstract available.
Similar articles
-
Hormone therapy and cardiovascular disease in the early postmenopause: the WHI data revisited.Climacteric. 2007 Jun;10(3):195-6. doi: 10.1080/13697130701401073. Climacteric. 2007. PMID: 17487646 No abstract available.
-
[Hormone therapy during menopause and risk of cardiovascular disease].Ugeskr Laeger. 2002 Apr 29;164(18):2414. Ugeskr Laeger. 2002. PMID: 12024849 Danish. No abstract available.
-
Focus on cardiovascular health: hormone replacement therapy, estrogen replacement therapy, and selective estrogen receptor modulators.J Am Osteopath Assoc. 2003 Feb;103(2 Suppl 2):S6-8. J Am Osteopath Assoc. 2003. PMID: 12625632 No abstract available.
-
[Hormone replacement therapy and cardiovascular risk in postmenopausal women].Med Pregl. 2009;62 Suppl 3:85-90. Med Pregl. 2009. PMID: 19702123 Review. Serbian.
-
[Effects of SERM on breast cancer and cardiovascular disease: making a comparison between raloxifene use and hormone replacement therapy on the risks of the diseases].Clin Calcium. 2004 Oct;14(10):81-4. Clin Calcium. 2004. PMID: 15577136 Review. Japanese.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources